Comparing Pegaptanib and Triamcinolone Efficacy in the Rat Choroidal Neovascularization Model

Abstract

In this animal model of choroidal neovascularization, intravitreal pegaptanib exhibited marginal or no effect on CNVM development; whereas intravitreal triamcinolone evoked robust inhibition of CNVMs. Clinical Relevance Pegaptanib treatment may be insufficient to prevent CNVM formation.